WALTHAM, Mass., November 15, 2024--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the ...

Thermo Fisher Scientific Inc. ( NYSE:TMO ) shareholders might be concerned after seeing the share price drop 10% in ...

Guion, leader of Thermo Fisher Scientific’s Pride+ BRG, spoke to myGwork about his journey from a closeted boy growing up in the AIDS epidemic, to a confident advocate for the LGBTQ+ community on a ...

The United Nations (UN) has reiterated the need to expedite projected emissions reductions from the use of fossil fuels.

The US Food and Drug Administration granted clearances for various tests for infectious diseases, coagulation disorders, and drug susceptibility.

DelveInsight's D-Dimer Testing Market Insights report provides the current and forecast market analysis, individual leading D ...

Investing.com -- Thermo Fisher Scientific Inc., a leading scientific instruments maker, reported third-quarter earnings that surpassed analyst expectations, while revenue fell slightly short of ...

The growing prevalence of cardiovascular and thrombotic disorders is driving strong demand for D-dimer testing. As blood clot-related risk factors continue to increase, the need for precise ...

Alveo Technologies, Inc. (Alveo), a leader in decentralized molecular diagnostics with its proprietary IntelliSense™ platform, today announced the launch of its first animal health diagnostic product, ...

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.